Suo FZ - Search Results

1

An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors.

Zheng YC, Chang J, Zhang T, Suo FZ, Chen XB, Liu Y, Zhao B, Yu B, Liu HM. Zheng YC, et al. Among authors: suo fz. Curr Med Chem. 2017;24(23):2496-2504. doi: 10.2174/0929867324666170509114321. Curr Med Chem. 2017. PMID: 28486922 Review.

2

Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.

Duan Y, Qin W, Suo F, Zhai X, Guan Y, Wang X, Zheng Y, Liu H. Duan Y, et al. Bioorg Med Chem. 2018 Dec 15;26(23-24):6000-6014. doi: 10.1016/j.bmc.2018.10.037. Epub 2018 Oct 29. Bioorg Med Chem. 2018. PMID: 30448189

3

Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A).

Li Z, Ding L, Li Z, Wang Z, Suo F, Shen D, Zhao T, Sun X, Wang J, Liu Y, Ma L, Zhao B, Geng P, Yu B, Zheng Y, Liu H. Li Z, et al. Acta Pharm Sin B. 2019 Jul;9(4):794-808. doi: 10.1016/j.apsb.2019.01.001. Epub 2019 Jan 5. Acta Pharm Sin B. 2019. PMID: 31384539 Free PMC article.

4

Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors.

Li ZH, Liu XQ, Geng PF, Suo FZ, Ma JL, Yu B, Zhao TQ, Zhou ZQ, Huang CX, Zheng YC, Liu HM. Li ZH, et al. Among authors: suo fz. ACS Med Chem Lett. 2017 Mar 6;8(4):384-389. doi: 10.1021/acsmedchemlett.6b00423. eCollection 2017 Apr 13. ACS Med Chem Lett. 2017. PMID: 28435523 Free PMC article.

5

Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation.

Sun K, Peng JD, Suo FZ, Zhang T, Fu YD, Zheng YC, Liu HM. Sun K, et al. Among authors: suo fz. Bioorg Med Chem Lett. 2017 Nov 15;27(22):5036-5039. doi: 10.1016/j.bmcl.2017.10.003. Epub 2017 Oct 3. Bioorg Med Chem Lett. 2017. PMID: 29037950

6

Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803.

Ma JL, Zhang T, Suo FZ, Chang J, Wan XB, Feng XJ, Zheng YC, Liu HM. Ma JL, et al. Among authors: suo fz. J Cell Biochem. 2018 Jun;119(6):4957-4966. doi: 10.1002/jcb.26741. Epub 2018 Mar 9. J Cell Biochem. 2018. PMID: 29384217

7

Identification of osimertinib (AZD9291) as a lysine specific demethylase 1 inhibitor.

Li ZR, Suo FZ, Hu B, Guo YJ, Fu DJ, Yu B, Zheng YC, Liu HM. Li ZR, et al. Among authors: suo fz. Bioorg Chem. 2019 Mar;84:164-169. doi: 10.1016/j.bioorg.2018.11.018. Epub 2018 Nov 16. Bioorg Chem. 2019. PMID: 30502627

8

Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors.

Li ZR, Wang S, Yang L, Yuan XH, Suo FZ, Yu B, Liu HM. Li ZR, et al. Among authors: suo fz. Eur J Med Chem. 2019 Mar 15;166:432-444. doi: 10.1016/j.ejmech.2019.01.075. Epub 2019 Feb 2. Eur J Med Chem. 2019. PMID: 30739825

9

Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors.

Wang S, Li ZR, Suo FZ, Yuan XH, Yu B, Liu HM. Wang S, et al. Among authors: suo fz. Eur J Med Chem. 2019 Apr 1;167:388-401. doi: 10.1016/j.ejmech.2019.02.039. Epub 2019 Feb 13. Eur J Med Chem. 2019. PMID: 30780087

10

Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors.

Liu HM, Suo FZ, Li XB, You YH, Lv CT, Zheng CX, Zhang GC, Liu YJ, Kang WT, Zheng YC, Xu HW. Liu HM, et al. Among authors: suo fz. Eur J Med Chem. 2019 Aug 1;175:357-372. doi: 10.1016/j.ejmech.2019.04.065. Epub 2019 Apr 29. Eur J Med Chem. 2019. PMID: 31096156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters